PubMed · 2012 · 141 citations · 23 references
MedicineDermatologyOncologyCutaneous OncologyImmunotherapyNeoplasiaCancer ImmunotherapyCancer MortalityMalignant NeoplasmsMelanocytic TumorsSkin Cancer EpidemiologyAnnual IncidenceMalignant Melanocytic TumorsMedian AgeMelanocytic Tumor PrognosisMelanoma DiagnosisMelanoma ImmunotherapyMelanoma IncidenceSkin Cancer Mortality
Ipilimumab (Yervoy) for metastatic melanoma
23
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong et al. · Journal of Clinical Oncology · 2009 · 4.6K citations · Full text
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert, L. Thomas, Igor Bondarenko et al. · New England Journal of Medicine · 2011 · 4.5K citations · Full text
Medicine, Oncology, Pharmacotherapy +12
Cancer immunotherapy: moving beyond current vaccines
Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo · Nature Medicine · 2004 · 3K citations · Full text
Medicine, Immunology, Oncology +14